Insider Shareholders with Direct Ownership of Elevation Oncology, Inc. (ELEV)
This section provides a comprehensive overview of the insiders with direct ownership of Elevation Oncology, Inc. (ELEV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Elevation Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,539,092 | 0 | 2,834,910 $1.33 Million | 1 |
Jun 29, 2021
Added 6.2%
|
|
|
Qiming U.S. Healthcare Fund Ii, L.P.
> 10% Shareholder |
2,370,142 | 0 | 2,370,142 $1.11 Million | 1 |
Jun 29, 2021
Added 11.65%
|
|
Vertex Global Hc Fund Ii Pte. Ltd.
> 10% Shareholder |
2,307,642 | 0 | 2,307,642 $1.08 Million | 1 |
Jun 29, 2021
Added 9.77%
|
| 2,608,167 | 702,737 | 1,905,430 $895,552 | 2 |
May 25, 2022
Reduced 26.94%
|
|
|
Joseph J Ferra Jr
CHIEF EXECUTIVE OFFICER |
200,873 | 75,602 | 125,271 $58,877 | 24 |
Feb 15, 2025
Reduced 6.85%
|
|
Valerie Malyvanh Jansen
CHIEF MEDICAL OFFICER |
17,500 | 5,189 | 12,311 $5,786 | 2 |
Feb 15, 2025
Reduced 29.65%
|
|
Tammy Furlong
CHIEF FINANCIAL OFFICER |
11,775 | 3,559 | 8,216 $3,861 | 10 |
Feb 15, 2025
Reduced 1.07%
|
|
David Dornan
CHIEF SCIENTIFIC OFFICER |
9,375 | 4,152 | 5,223 $2,454 | 2 |
Feb 15, 2025
Reduced 44.29%
|
| 0 | 47,330 | 0 $0 | 2 |
Sep 01, 2023
Reduced 100.0%
|